| 2025 | 2024 | 2023 | 2022 | 2020 | 2019 | 2018 | 2017 | 2016 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 64,5 k € | +172.9% | 23,6 k € | -30.3% | 33,9 k € | -32.6% | 50,3 k € | -35.6% | 78,1 k € | -22.4% | 100,7 k € | +238.8% | -72,6 k € | -78.2% | -40,7 k € | +3.3% | -42,1 k € | |
| EBITDA | 63,8 k € | +177.7% | 23,0 k € | -31.0% | 33,3 k € | -32.0% | 49,0 k € | -36.8% | 77,6 k € | -22.5% | 100,1 k € | +238.1% | -72,5 k € | -5.3% | -68,8 k € | +37.7% | -110,4 k € | |
| Operating profit | 63,8 k € | +177.7% | 23,0 k € | -31.0% | 33,3 k € | -21.3% | 42,4 k € | -45.4% | 77,6 k € | -22.4% | 100,0 k € | +237.2% | -72,9 k € | -5.3% | -69,2 k € | +37.5% | -110,7 k € | |
| Profit/loss | 42,8 k € | +298.7% | 10,7 k € | -39.3% | 17,7 k € | -49.7% | 35,2 k € | -48.7% | 68,7 k € | -27.6% | 94,9 k € | +226.4% | -75,1 k € | -0.7% | -74,5 k € | +33.8% | -112,6 k € | |
| Equity | 75,4 k € | +131.6% | 32,5 k € | +49.3% | 21,8 k € | +433.1% | 4,1 k € | +104.4% | -92,5 k € | +42.6% | -161,2 k € | +37.1% | -256,0 k € | -41.5% | -181,0 k € | -70.0% | -106,4 k € | |
| Total assets | 99,4 k € | -27.7% | 137,6 k € | -8.6% | 150,5 k € | +7.1% | 140,5 k € | -51.7% | 291,1 k € | -9.5% | 321,5 k € | +1139.0% | 26,0 k € | -68.9% | 83,4 k € | -51.5% | 171,8 k € | |
| Cash | 18,8 k € | +31.8% | 14,2 k € | +5874.2% | 238,5 € | -97.1% | 8,3 k € | +106.2% | 4,0 k € | +263.9% | 1,1 k € | -58.0% | 2,6 k € | -76.7% | 11,3 k € | -74.9% | 45,0 k € | |
| Debts | 24,0 k € | -77.1% | 105,0 k € | -18.4% | 128,7 k € | -5.6% | 136,4 k € | -64.4% | 383,6 k € | -20.5% | 482,7 k € | +71.2% | 282,0 k € | +6.7% | 264,3 k € | -5.0% | 278,3 k € | |
| Staff | — | — | — | — | — | — | — | 0,5 | 1,6 | |||||||||
Private limited company · Gent · incorporated on 29/01/2016
Private limited company profitable and well capitalised. Cash position rising (+31.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
NOREVA BE is a Private limited company incorporated in 2016. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Gent.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette